ONCY

#3427
Oncolytics Biotech Inc. - Common Stock
1.0 4 USD
+10.64%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
1.04
1.04
Faixa anual
0.33
1.51
Mudança diária
+10.64%
Mudança mensal
+14.29%
Mudança em 6 meses
+4.00%
Mudança anual
+173.68%
Fechamento anterior
0.9 4
Open
1.0 4
Mínimo
1.0 4
High
1.0 4
Volume
30
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor Q4, 24Q4, 25Q1, 26 TTM

Oncolytics Biotech Inc. - Common Stock

Oncolytics Biotech Inc. is a Canadian company headquartered in Calgary, Alberta, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses.

Notícias